Christopher DAngelo
Overview
Explore the profile of Christopher DAngelo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
200
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sankhi B, DAngelo C, Thompson D, Tyagi P
Sci Rep
. 2025 Feb;
15(1):5576.
PMID: 39955357
Magnetic Tunnel Junction-based molecular spintronics devices (MTJMSDs) hold great potential for integrating paramagnetic molecules with ferromagnetic electrodes, creating a diverse array of metamaterials with novel magnetic behaviors. Understanding interactions, especially...
2.
Elsallab M, Ellithi M, Lunning M, DAngelo C, Ma J, Perales M, et al.
Blood
. 2024 Mar;
143(20):2099-2105.
PMID: 38483155
Second primary malignancies were reported in 536 of 12 394 (4.3%) adverse event reports following chimeric antigen receptor T-cell therapies in the Food and Drug Administration Adverse Event Reporting System....
3.
Kumar S, Callander N, Adekola K, Anderson Jr L, Baljevic M, Baz R, et al.
J Natl Compr Canc Netw
. 2024 Jan;
22(1D):e240001.
PMID: 38244272
The treatment of Waldenström macroglobulinemia/lymphoplasmacytic lymphoma (WM/LPL) has evolved to include several new options. The NCCN Guidelines for WM/LPL provide a framework on which to base decisions regarding diagnosis, treatment,...
4.
Kumar S, Callander N, Adekola K, Anderson Jr L, Baljevic M, Baz R, et al.
J Natl Compr Canc Netw
. 2023 Dec;
21(12):1281-1301.
PMID: 38081133
The treatment of relapsed/refractory multiple myeloma (MM) has evolved to include several new options. These include new combinations with second generation proteasome inhibitors (PI); second generation immunomodulators, monoclonal antibodies, CAR...
5.
Mutunga E, DAngelo C, Tyagi P
Sci Rep
. 2023 Sep;
13(1):16201.
PMID: 37758736
Understanding the magnetic molecules' interaction with different combinations of metal electrodes is vital to advancing the molecular spintronics field. This paper describes experimental and theoretical understanding showing how paramagnetic single-molecule...
6.
Kumar S, Callander N, Adekola K, Anderson Jr L, Baljevic M, Campagnaro E, et al.
J Natl Compr Canc Netw
. 2023 Jan;
21(1):67-81.
PMID: 36652935
Primary systemic light chain amyloidosis (SLCA) is characterized by production of light chains that get converted to amyloid fibrils with an affinity for visceral organs and causing organ dysfunction. The...
7.
Dahal B, Grizzle A, DAngelo C, Lamberti V, Tyagi P
Int J Mol Sci
. 2022 Nov;
23(22).
PMID: 36430956
Molecular spintronics devices (MSDs) attempt to harness molecules' quantum state, size, and configurable attributes for application in computer devices-a quest that began more than 70 years ago. In the vast...
8.
DAngelo C, Sudakaran S, Asimakopoulos F, Hematti P, El-Gamal D, Safdar N, et al.
Leuk Lymphoma
. 2022 Oct;
64(1):87-97.
PMID: 36218226
The gut microbiome is an important feature of host immunity with associations to hematologic malignancies and cellular therapy. We evaluated the gut microbiome and dietary intake in patients with multiple...
9.
Al-Kadhimi Z, Pirruccello S, Gul Z, Maness-Harris L, Bhatt V, Gundabolu K, et al.
Bone Marrow Transplant
. 2022 Aug;
57(10):1629-1631.
PMID: 35953707
No abstract available.
10.
Grizzle A, DAngelo C, Martinez-Lillo J, Tyagi P
RSC Adv
. 2022 May;
11(51):32275-32285.
PMID: 35495500
Paramagnetic single-molecule magnets (SMMs) interacting with the ferromagnetic electrodes of a magnetic tunnel junction (MTJ) produce a new system. The properties and future scope of new systems differ dramatically from...